Related Experiment Video
Updated: Oct 4, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.4K
White matter microstructures in Parkinson's disease with and without impulse control behaviors
Haruka Takeshige-Amano1,2, Taku Hatano1, Koji Kamagata3
1Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 1138421, Japan.
Annals of Clinical and Translational Neurology
|February 9, 2022
Summary
Parkinson's disease patients without impulse control behaviors show distinct white matter changes compared to those with impulse control behaviors. These differences involve myelin and axonal integrity in key brain networks.
Area of Science:
- Neuroimaging
- Neuroscience
- Neurology
Background:
- Impulse control behaviors (ICBs) in Parkinson's disease (PD) are linked to dopaminergic therapy and brain network alterations.
- The exact neurobiological underpinnings of ICBs in PD require further investigation.
Purpose of the Study:
- To investigate white matter microstructure differences in PD patients with and without ICBs.
- Utilize advanced diffusion MRI and magnetization transfer saturation (MT-sat) imaging for comprehensive assessment.
Main Methods:
- Compared 19 PD patients with ICBs (PD-ICBs), 18 PD patients without ICBs (PD-nICBs), and 20 healthy controls (HCs).
- Employed diffusion tensor imaging (DTI), diffusion kurtosis imaging, neurite orientation dispersion and density imaging, and MT-sat imaging.
- Analyzed data using tract-based spatial statistics (TBSS), regions of interest (ROIs), and tract-specific analysis (TSA).
Main Results:
- PD-nICBs exhibited significant white matter alterations across numerous tracts compared to HCs.
- PD-ICBs showed only partial changes in several white matter parameters.
- PD-nICBs had reduced axial kurtosis, myelin volume fraction, and orientation dispersion index in specific white matter tracts compared to PD-ICBs.
Conclusions:
- White matter microstructural differences exist between PD patients with and without ICBs.
- Alterations in myelin and axonal integrity within reward and visual-emotional processing pathways may distinguish PD-nICBs from PD-ICBs.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
804
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
804
Parkinson's Disease: Treatment
428
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
428
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K

